Supervised pelvic floor muscle training improves sexual function and d
Supervised pelvic floor muscle training improves sexual function and diminishes sexual distress in women with multiple sclerosis: a randomized controlled study
What it found
A paper reports the results; we have not read it yet. See Papers below.
What it measured
Main measures
Effect of pelvic floor muscle training (PFMT) on improving sexual function and sexual distress in women suffering from MS measured using the Female Sexual Function Index (FSFI) and the Female Sexual Distress Scale-Revised (FSDS-R) questionnaires scores at the beginning and end of the twelve-week study
Bladder, bowel and sexual function
Other measures (1)
There are no secondary outcome measures
Who could take part
Relapsing MS · 18 to 45
Show the full criteria
Inclusion criteria
Inclusion: 1. 18 years of age or older 2. Diagnosis of relapsing-remitting MS 3. Stable condition for a minimum period of six months 4. Kurtzke’s Expanded Disability Status Scale (EDSS) score < 4 5. Women sexually active for at least four weeks 6. Cognitive ability to complete the questionnaires and study protocol 7. Ability to contract PFM evaluated by the primary investigator Exclusion: 1. Previous pelvic floor muscle training program 2. Ongoing pregnancy 3. Child delivery within the previous six months 4. Urinary or faecal incontinence 5. Pelvic organ prolapses greater than stage I 6. Perimenopause or menopause period
Exclusion criteria
Not separately supplied in the registry.
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
Background and study aims Pelvic floor muscle training (PFMT) contributes to better sexual function, as muscle strength and ability to properly contract to improve vaginal receptivity and responsiveness, orgasm and sexual pleasure. Multiple sclerosis (MS) is the most common chronic nervous system disorder leading to sexual dysfunction, with a prevalence of 40-70%. More than a third of MS patients experience signs of pelvic floor weakness. The primary outcome of this study is to evaluate the effect of PFMT on improving sexual function and sexual distress in women suffering from MS. Who can participate? Adult women aged 18-45 years old with MS What does the study involve? In this study, women suffering from MS will be included in an intervention Group A (12 weeks of PFMT), and in a control Group B (observation group; negative control group). All women will be assessed with the Female Sexual Function Index (FSFI) and Female Sexual Distress Scale-Revised (FSDS-R) at the study's beginning and end. What are the possible benefits and risks of participating? Possible benefits include better sexual function. No risks are expected from the pelvic floor exercises. Where is the study run from? Ey Prattein Rehabilitation Centre (Greece) When is the study starting and how long is it expected to run for? May 2021 to May 2023 Who is funding the study? Investigator initiated and funded Who is the main contact? Athanasios Zachariou (Assistant Prof Urology), zahariou@otenet.gr (Greece)
Papers
Results
Paper 38248789
Loading reviews and guidelines…
History
Started
Sept 2021
Finished
May 2023